$25,175 in IBM Stock vs. One $685 Put. Same Risk.
1 extracted signal · 0 resolved · 1 still active
tastyliveIndependent analyst profile- Source published
- 27 Oct 2026, 02:00 UTC
- Recorded by Tahlil Plus
- 27 Oct 2026, 03:23 UTC

AI-generated source summary
The analysis focuses on comparing the strategy of buying 100 shares of IBM at $251.61 with selling one IBM put option with a strike price of $245 and a credit of $6.85 per share. The maximum loss for buying the stock outright is approximately $25,000, while selling the put limits the maximum loss to around $23,815, suggesting a slightly lower risk profile for the short put strategy. If the stock price stays above the $245 strike at expiration, the put seller keeps the $685 credit. If the stock price rises 20% annually, buying the stock yields a profit of $5,000 over a year, while selling 12 monthly puts at $680 each yields $8,160 in premiums, representing a 32.6% stock gain to match the premiums. However, a single loss on a short put can negate several months of gains. The net cost per share if assigned on the short put would be $238.15 ($245 strike - $6.85 credit). The analysis suggests that if one anticipates a significant rally in IBM, buying the stock might be more profitable, whereas a more modest rally or sideways movement would favor selling the put due to the premium collected and theta decay. The analysis highlights the capital efficiency of selling a put compared to buying stock, as it only requires margin rather than the full share price.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
tastylive
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
